Phase 3 Recurrent Nasopharyngeal Carcinoma Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University176 enrolled7 locationsNCT06228079
Recruiting
Phase 3
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University154 enrolled7 locationsNCT06235203
Recruiting
Phase 3
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT03907826
Recruiting
Phase 3
Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University204 enrolled1 locationNCT04376866